GFG Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.67M Buy
3,174
+2,450
+338% +$2.89M 0.96% 28
2026
Q2
$868K Buy
724
+7
+1% +$7.15K 0.24% 53
2026
Q1
$659K Buy
717
+624
+671% +$633K 0.21% 55
2025
Q4
$100K Buy
+93
New +$88.9K 0.04% 63
2025
Q3
– Sell
-84
Closed -$65.5K – 216
2025
Q2
$65.5K Sell
84
-640
-88% -$497K 0.02% 94
2025
Q1
$598K Buy
724
+415
+134% +$345K 0.18% 63
2024
Q4
$239K Buy
+309
New +$256K 0.06% 98

Other funds holding LLY

GFG Capital's LLY Position: Q3 2026 in Review

GFG Capital increased its Eli Lilly (LLY) stake by 338% in Q3 2026, buying an estimated $2.89M and bringing the position to 3,174 shares worth $3.67M. The position accounts for 0.96% of the portfolio, ranked #28.

GFG Capital first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 960 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • GFG Capital held 3,174 shares of Eli Lilly worth $3.67M as of Q3 2026.
  • GFG Capital bought 2,450 Eli Lilly shares in Q3 2026, an estimated $2.89M.
  • Eli Lilly made up 0.96% of GFG Capital's portfolio in Q3 2026, its #28 holding.
  • GFG Capital first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 960 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on GFG Capital's 13F filing for Q3 2026, filed 16 Oct 2026.